#Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants | Journal of Natural Products
https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c00946
#treatment
https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c00946
#treatment
ACS Publications
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
As a complement to vaccines, small-molecule therapeutic agents are needed to treat or prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, which cause COVID-19. Affinity selection–mass spectrometry was used…